Inogen
在场
高管
查看带有其 14 名主要高管的组织结构图
Inogen 搜索最多的简介
- Kevin Smith, Director, President and Chief Executive Officer
- Tom West, Director
- Heather Rider, Director
高管在Inogen变化
- Michael BourqueMichael Bourque 将于20243月4作为 Chief Financial Officer 加入公司 (新闻发布的2024一月26号).
- Kevin Smith已作为Director, President and Chief Executive Officer加入公司 (新闻发布的2023十一月14号).
- Kristin Caltrider, Chief Financial Officer and Director, 已经离开公司 (新闻发布的2023九月8号).
创建提醒
跟踪 Inogen 的高管变动
生物技术
Inogen 拥有 2,279 家竞争者，其中包括 Eurofins (卢森堡)、Lonza (瑞士) 和 Adaptive Phage Therapeutics (美国(美洲))。
Popular M&A news in 生物技术
- Metsera 刚刚宣布为 290 筹款数百万美元。 (公布2024四月23号).
- Histogen has filed for bankruptcy protection (公布2024四月19号).
- Bruker has announced the acquisition of NanoString Technologies (公布2024四月18号).
生物技术 行业的其他推荐联系人
消息
Inogen 的最新新闻稿
- Inogen to Report First Quarter 2024 Financial Results on May 7, 2024
- Press Releases
- Inogen To Present at 23rd Annual Needham Virtual Healthcare Conference
- Press Releases
- Inogen, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
- Inogen Announces Fourth Quarter and Full-Year 2023 Financial Results
- Inogen to Report Fourth Quarter and Full Year 2023 Financial Results on February 27, 2024
- Inogen Names Michael Bourque as New Chief Financial Officer
- Inogen Announces Leadership Change with the Appointment of Kevin Smith as President and CEO
- Inogen to Present at Upcoming Investor Conferences in November 2023
- View more press releases Close
关于 Inogen 的社交媒体
保持联系
通过电子邮件联系联系该企业高管，包括 Glenn Boehnlein 
